U.S. pharmaceutical company Pfizer and its German partner BioNTech said Friday a new study indicates their COVID-19 booster vaccination provides significant antibody protection against the omicron variant and its subvariants among adults. The companies introduced a new booster targeting the omicron variant in September, and U.S. Food and Drug Administration (FDA) approved it for use … continue reading -> “Pfizer Study: COVID Booster Significantly Ups Protection Against Variants”